reed’s

Global Genes Global Advocacy Alliance member focused on rare disease support, education, advocacy, or research. Reed’s Reach for 15q13.3 is dedicated to accelerating the development of diagnostics, treatments, and curative therapies for 15q13.3 microdeletion syndrome and its associated neurodevelopmental and psychiatric disorders, including autism spectrum disorder, schizophrenia, and epilepsy. We achieve this by supporting and funding scientific and clinical research to develop translational therapies. Directory information only; not medical advice, legal advice, or endorsement. Services and eligibility should be confirmed with the organization.